Science Explorer Back to mapMap

Most cited papers from Aradigm (United States)

What are the most cited papers from Aradigm (United States)?

The most cited paper from Aradigm (United States) is "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial" (David J. Serisier, Diana Bilton, Anthony De Soyza et al., 2013), with 250 citations. Next come "Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆" (225) and "Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials" (214).

Showing 50 of 60 papers. Every paper with more than 18 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial David J. Serisier, Diana Bilton, Anthony De Soyza et al. · Thorax Open access 16 May 2013 250
2 Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆ Pradipta Chattopadhyay, Boris Yu Shekunov, DaBin Yim et al. · Advanced Drug Delivery Reviews 24 May 2007 225
3 Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials Charles Haworth, Diana Bilton, James Duncan Chalmers et al. · The Lancet Respiratory Medicine Open access 15 Jan 2019 214
4 Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects Evangelia Daviskas, Sandra D. Anderson, Igor Gonda et al. · European Respiratory Journal Open access Apr 1996 186
5 Development of Liposomal Ciprofloxacin to Treat Lung Infections David C. Cipolla, Jim Blanchard, Igor Gonda · Pharmaceutics Open access Mar 2016 176
6 Drug nanocrystallisation within liposomes Li Tang, David C. Cipolla, Thomas Rades et al. · Journal of Controlled Release Open access 2 Sep 2018 155
7 Liposomal Formulations for Inhalation David C. Cipolla, Igor Gonda, Hak‐Kim Chan · Therapeutic Delivery Aug 2013 155
8 Pharmacokinetics and Pharmacodynamics of Inhaled versus Intravenous Morphine in Healthy Volunteers Mark Dershwitz, John L. Walsh, Richard J. Morishige et al. · Anesthesiology Open access Sep 2000 141
9 Spray Dried Powders and Powder Blends of Recombinant Human Deoxyribonuclease (rhDNase) for Aerosol Delivery Hak‐Kim Chan, Andy Clark, Igor Gonda et al. · Pharmaceutical Research Apr 1997 141
10 Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans David C. Cipolla, Boris Yu Shekunov, Jim Blanchard et al. · Advanced Drug Delivery Reviews Review 10 May 2014 123
11 Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery Laurence E. Mather, Annie Woodhouse, Marcy Ward et al. · British Journal of Clinical Pharmacology Open access Jul 1998 110
12 Pulmonary Formulations: What Remains to be Done? Jeffry G. Weers, John Bell, Hak‐Kim Chan et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Dec 2010 106
13 Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients Gernot A Brunner, B. Balent, Martin Ellmerer et al. · Diabetologia Open access 9 Mar 2001 102
14 The Ascent of Pulmonary Drug Delivery Igor Gonda · Journal of Pharmaceutical Sciences Jul 2000 97
15 Limits on the Peculiar Velocities of Two Distant Clusters Using the Kinematic Sunyaev‐Zeldovich Effect W. L. Holzapfel, Peter A. R. Ade, S. Church et al. · The Astrophysical Journal Open access 20 May 1997 89
16 Measurement of the Hubble Constant from X‐Ray and 2.1 Millimeter Observations of Abell 2163 W. L. Holzapfel, M. Arnaud, Peter A. R. Ade et al. · The Astrophysical Journal Open access 10 May 1997 88
17 The AERX™ Aerosol Delivery System Jeff Schuster, Reid Rubsamen, Peter M. Lloyd et al. · Pharmaceutical Research Mar 1997 81
18 Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia Hui Xin Ong, Daniela Traini, David C. Cipolla et al. · Pharmaceutical Research 25 Jul 2012 80
19 Modifying the Release Properties of Liposomes Toward Personalized Medicine David C. Cipolla, Huiying Wu, Igor Gonda et al. · Journal of Pharmaceutical Sciences Open access 8 Apr 2014 73
20 Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation Isra Khatib, Dipesh Khanal, Juanfang Ruan et al. · International Journal of Pharmaceutics 14 Jun 2019 72
21 Development of Safety Qualification Thresholds and Their Use in Orally Inhaled and Nasal Drug Product Evaluation Douglas J. Ball, Juliette Blanchard, David Jacobson‐Kram et al. · Toxicological Sciences 18 Jan 2007 72
22 Pulmonary Insulin Administration Using the AERx® System: Physiological and Physicochemical Factors Influencing Insulin Effectiveness in Healthy Fasting Subjects Stephen J. Farr, A. McElduff, Laurence E. Mather et al. · Diabetes Technology & Therapeutics Jun 2000 71
23 Symposium Summary Jeffrey S. Tepper, Philip J. Kuehl, Stuart Cracknell et al. · International Journal of Toxicology Open access 7 Feb 2016 65
24 Analgesic Efficacy of Inhaled Morphine in Patients after Bunionectomy Surgery John Thipphawong, Najib Babul, Richard J. Morishige et al. · Anesthesiology Sep 2003 65
25 Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system* Marcy Ward, A Woodhouse, Laurence E. Mather et al. · Clinical Pharmacology & Therapeutics Dec 1997 64
26 Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation David C. Cipolla, Huiying Wu, Simon J. Eastman et al. · Journal of Pharmaceutical Sciences Open access 26 Nov 2013 60
27 Inhaled Antibiotics to Treat Lung Infection David C. Cipolla, Hak‐Kim Chan · Pharmaceutical Patent Analyst 22 Aug 2013 57
28 Formulation technology to repurpose drugs for inhalation delivery David C. Cipolla, Igor Gonda · Drug Discovery Today Therapeutic Strategies 22 Aug 2011 56
29 Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report Carole D. Evans et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery 13 Mar 2012 56
30 In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation Hui Xin Ong, Faiza Benaouda, Daniela Traini et al. · European Journal of Pharmaceutics and Biopharmaceutics Open access 10 Jul 2013 54
31 Deposition, Imaging, and Clearance: What Remains to be Done? G. Scheuch, William D. Bennett, Lars Borgström et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Dec 2010 54
32 Pulmonary delivery of opioids as pain therapeutics Stephen J. Farr, Babatunde Otulana · Advanced Drug Delivery Reviews Review 13 Aug 2006 54
33 Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies James Duncan Chalmers, David C. Cipolla, Bruce Thompson et al. · European Respiratory Journal Open access 18 Jun 2020 52
34 Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler Stephen J. Farr, Simon Warren, Peter M. Lloyd et al. · International Journal of Pharmaceutics Mar 2000 52
35 The Sunyaev‐Zeldovich Infrared Experiment: A Millimeter‐Wave Receiver for Cluster Cosmology W. L. Holzapfel, T. M. Wilbanks, Peter A. R. Ade et al. · The Astrophysical Journal Open access 10 Apr 1997 52
36 Formation of drug nanocrystals under nanoconfinement afforded by liposomes David C. Cipolla, Hung‐Jen Wu, Stefan Salentinig et al. · RSC Advances Open access 2016 48
37 An Upper Limit to Arcminute‐Scale Anisotropy in the Cosmic Microwave Background Radiation at 142 GHz S. E. Church, K. M. Ganga, P. A. R. Ade et al. · The Astrophysical Journal Open access Aug 1997 48
38 Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women Sonia L. Davison, John Thipphawong, Jim Blanchard et al. · The Journal of Clinical Pharmacology 12 Jan 2005 40
39 Inhalation delivery systems with compliance and disease management capabilities Igor Gonda, Jeff Schuster, Reid Rubsamen et al. · Journal of Controlled Release Apr 1998 40
40 Personalizing Aerosol Medicine: Development of Delivery Systems Tailored to the Individual David C. Cipolla, Hak‐Kim Chan, Julius Schuster et al. · Therapeutic Delivery Nov 2010 39
41 Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin James D. Blanchard, Valerie D. Elias, David C. Cipolla et al. · Antimicrobial Agents and Chemotherapy Open access 17 Jul 2018 36
42 Aerosolization of lipoplexes using AERx® pulmonary delivery system Deepa Deshpande, James D. Blanchard, Sudarshan Srinivasan et al. · AAPS PharmSci Open access Sep 2002 36
43 The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy Karleigh A. Hamblin, Jonathan P. Wong, James D. Blanchard et al. · Frontiers in Cellular and Infection Microbiology Open access 18 Jun 2014 33
44 An Upper Limit to Arcminute Scale Anisotropy in the Cosmic Microwave Background Radiation at 142 GHz S. Church, Ken M. Ganga, Peter A. R. Ade et al. Preprint 1997 32
45 Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague Karleigh A. Hamblin, Stuart J. Armstrong, Kay B. Barnes et al. · Frontiers in Microbiology Open access 6 Feb 2017 32
46 Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4 Karleigh A. Hamblin, Stuart J. Armstrong, Kay B. Barnes et al. · Antimicrobial Agents and Chemotherapy Open access 17 Mar 2014 32
47 Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals David C. Cipolla, Huiying Wu, Igor Gonda et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 15 Oct 2015 31
48 Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever Isobel H. Norville, Graham J. Hatch, Kevin R. Bewley et al. · Antimicrobial Agents and Chemotherapy Open access 8 Jul 2014 31
49 Pulmonary Insulin Administration Using the AERx ® Insulin Diabetes System John Thipphawong, Babatunde Otulana, Per Clauson et al. · Diabetes Technology & Therapeutics Aug 2002 28
50 Investigation of Protein-Surfactant Interactions by Analytical Ultracentrifugation and Electron Paramagnetic Resonance: The Use of Recombinant Human Tissue Factor as an Example LaToya S. Jones, David C. Cipolla, Jun Liu et al. · Pharmaceutical Research Jun 1999 28

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.